From Mersana Adds $4M For Next-Generation “Armed” Cancer Drugs:

MersanaLogo

MersanaLogo—

Mersana is developing antibody drug conjugates to treat cancer.

Underwriters and Partners

Xconomy Insight

Sponsored · Whitepaper
CMC in Drug Development and Life Cycle Management
CMC in Drug Development and Life Cycle Management
PRA Health Sciences

From Our Partners · Special Report
Robert Langer reveals secrets to early-stage biotech success
Advice for funding and future transformational opportunities

Sponsored · Whitepaper
What to Include in Your Life Sciences Company Fundraising Pitch Deck
What the most successful life sciences fundraising pitch decks all have in common
Brex

Xconomy on Demand

We offer a number of ways to subscribe for free!